Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17726565rdf:typepubmed:Citationlld:pubmed
pubmed-article:17726565lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17726565lifeskim:mentionsumls-concept:C0042025lld:lifeskim
pubmed-article:17726565lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:17726565lifeskim:mentionsumls-concept:C0175672lld:lifeskim
pubmed-article:17726565lifeskim:mentionsumls-concept:C0183346lld:lifeskim
pubmed-article:17726565lifeskim:mentionsumls-concept:C1524072lld:lifeskim
pubmed-article:17726565lifeskim:mentionsumls-concept:C0449445lld:lifeskim
pubmed-article:17726565pubmed:issue3lld:pubmed
pubmed-article:17726565pubmed:dateCreated2008-2-4lld:pubmed
pubmed-article:17726565pubmed:abstractTextWe present comparative short-term experience with the transvaginal (TVT) and the transobturator (TVT-O) approaches for the treatment of stress urinary incontinence (SUI). We studied 315 women with SUI, treated with a tension-free tape placement. The TVT approach was applied in 265 women, while 50 women were treated by the TVT-O approach. The mean operation time was 25 and 17 min in the TVT and TVT-O group, respectively (p<0.001). In the TVT group, continence rates were 87% after 1 year, while in the TVT-O group, the continence rate was 94%. Postoperative pain was reported in 14.4 and 28% of the TVT and TVT-O patients, respectively (p=0.02). Complications such as bladder perforation, retropubic hematoma, and urinary retention took place only in the TVT group. Urinary tract infections were recorded in 20 and 8% of the TVT and TVT-O patients, respectively (p=0.04), while vaginal erosion took place in 1.5 and 2% and de novo urgency in 14 and 8%. Both approaches show high rates of cure at the first postoperative year, while complications are less with the TVT-O procedure.lld:pubmed
pubmed-article:17726565pubmed:languageenglld:pubmed
pubmed-article:17726565pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17726565pubmed:citationSubsetIMlld:pubmed
pubmed-article:17726565pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17726565pubmed:statusMEDLINElld:pubmed
pubmed-article:17726565pubmed:monthMarlld:pubmed
pubmed-article:17726565pubmed:authorpubmed-author:CharalambousS...lld:pubmed
pubmed-article:17726565pubmed:authorpubmed-author:RombisVVlld:pubmed
pubmed-article:17726565pubmed:authorpubmed-author:Giannakopoulo...lld:pubmed
pubmed-article:17726565pubmed:authorpubmed-author:TouloupidisSSlld:pubmed
pubmed-article:17726565pubmed:authorpubmed-author:PapatsorisA...lld:pubmed
pubmed-article:17726565pubmed:authorpubmed-author:FatlesGGlld:pubmed
pubmed-article:17726565pubmed:authorpubmed-author:KalaitzisChChlld:pubmed
pubmed-article:17726565pubmed:volume19lld:pubmed
pubmed-article:17726565pubmed:ownerNLMlld:pubmed
pubmed-article:17726565pubmed:authorsCompleteYlld:pubmed
pubmed-article:17726565pubmed:pagination357-60lld:pubmed
pubmed-article:17726565pubmed:dateRevised2011-8-18lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:meshHeadingpubmed-meshheading:17726565...lld:pubmed
pubmed-article:17726565pubmed:year2008lld:pubmed
pubmed-article:17726565pubmed:articleTitleTransvaginal vs transobturator approach for synthetic sling placement in patients with stress urinary incontinence.lld:pubmed
pubmed-article:17726565pubmed:affiliationDepartment of Urology, Hippocratio General Hospital of Thessaloniki, Thessaloniki, Greece.lld:pubmed
pubmed-article:17726565pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17726565pubmed:publicationTypeComparative Studylld:pubmed